[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Research Report 2024(Status and Outlook)

August 2024 | 102 pages | ID: G8355911FEEBEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

The Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size was estimated at USD 389.15 million in 2023 and is projected to reach USD 475.60 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.

This report provides a deep insight into the global VPM1002 (Tuberculosis BCG Based Vaccine) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global VPM1002 (Tuberculosis BCG Based Vaccine) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the VPM1002 (Tuberculosis BCG Based Vaccine) market in any manner.

Global VPM1002 (Tuberculosis BCG Based Vaccine) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Vakzine Projekt Management (VPM)

Serum Institute of India

Market Segmentation (by Type)

by Dosage

0.5ml Package

1ml Package

2ml Package

Other

by Type of Inoculator

Initial Vaccinate

Revaccination

Market Segmentation (by Application)

0-5 Years Old

5-18 Years Old

18-45 Years Old

45-65 Years Old

?65 Years Old

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the VPM1002 (Tuberculosis BCG Based Vaccine) Market
  • Overview of the regional outlook of the VPM1002 (Tuberculosis BCG Based Vaccine) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the VPM1002 (Tuberculosis BCG Based Vaccine) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of VPM1002 (Tuberculosis BCG Based Vaccine)
1.2 Key Market Segments
  1.2.1 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Type
  1.2.2 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET COMPETITIVE LANDSCAPE

3.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Manufacturers (2019-2024)
3.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Manufacturers (2019-2024)
3.3 VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers VPM1002 (Tuberculosis BCG Based Vaccine) Sales Sites, Area Served, Product Type
3.6 VPM1002 (Tuberculosis BCG Based Vaccine) Market Competitive Situation and Trends
  3.6.1 VPM1002 (Tuberculosis BCG Based Vaccine) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest VPM1002 (Tuberculosis BCG Based Vaccine) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) INDUSTRY CHAIN ANALYSIS

4.1 VPM1002 (Tuberculosis BCG Based Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2019-2024)
6.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Market Share by Type (2019-2024)
6.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Price by Type (2019-2024)

7 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Sales by Application (2019-2024)
7.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Application (2019-2024)
7.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2019-2024)

8 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY REGION

8.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
  8.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
  8.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region
8.2 North America
  8.2.1 North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Vakzine Projekt Management (VPM)
  9.1.1 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Basic Information
  9.1.2 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
  9.1.3 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
  9.1.4 Vakzine Projekt Management (VPM) Business Overview
  9.1.5 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) SWOT Analysis
  9.1.6 Vakzine Projekt Management (VPM) Recent Developments
9.2 Serum Institute of India
  9.2.1 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Basic Information
  9.2.2 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
  9.2.3 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
  9.2.4 Serum Institute of India Business Overview
  9.2.5 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) SWOT Analysis
  9.2.6 Serum Institute of India Recent Developments

10 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET FORECAST BY REGION

10.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast
10.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
  10.2.3 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region
  10.2.4 South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of VPM1002 (Tuberculosis BCG Based Vaccine) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2025-2030)
  11.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2025-2030)
11.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Application (2025-2030)
  11.2.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) Forecast by Application
  11.2.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Comparison by Region (M USD)
Table 5. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VPM1002 (Tuberculosis BCG Based Vaccine) as of 2022)
Table 10. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers VPM1002 (Tuberculosis BCG Based Vaccine) Sales Sites and Area Served
Table 12. Manufacturers VPM1002 (Tuberculosis BCG Based Vaccine) Product Type
Table 13. Global VPM1002 (Tuberculosis BCG Based Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of VPM1002 (Tuberculosis BCG Based Vaccine)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. VPM1002 (Tuberculosis BCG Based Vaccine) Market Challenges
Table 22. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Type (Kilotons)
Table 23. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (M USD)
Table 24. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) by Type (2019-2024)
Table 25. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2019-2024)
Table 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Type (2019-2024)
Table 27. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Share by Type (2019-2024)
Table 28. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price (USD/Ton) by Type (2019-2024)
Table 29. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) by Application
Table 30. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application
Table 31. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2019-2024)
Table 33. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Application (2019-2024) & (M USD)
Table 34. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2019-2024)
Table 35. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2019-2024)
Table 36. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2019-2024)
Table 38. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2019-2024) & (Kilotons)
Table 43. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Basic Information
Table 44. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 45. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Vakzine Projekt Management (VPM) Business Overview
Table 47. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) SWOT Analysis
Table 48. Vakzine Projekt Management (VPM) Recent Developments
Table 49. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Basic Information
Table 50. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 51. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Serum Institute of India Business Overview
Table 53. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) SWOT Analysis
Table 54. Serum Institute of India Recent Developments
Table 55. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of VPM1002 (Tuberculosis BCG Based Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD), 2019-2030
Figure 5. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) (2019-2030)
Figure 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (M USD)
Figure 11. VPM1002 (Tuberculosis BCG Based Vaccine) Sales Share by Manufacturers in 2023
Figure 12. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers in 2023
Figure 13. VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by VPM1002 (Tuberculosis BCG Based Vaccine) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Type
Figure 18. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2019-2024)
Figure 19. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2023
Figure 20. Market Size Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2019-2024)
Figure 21. Market Size Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application
Figure 24. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2019-2024)
Figure 25. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application in 2023
Figure 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2019-2024)
Figure 27. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application in 2023
Figure 28. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2019-2024)
Figure 29. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2019-2024)
Figure 30. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2023
Figure 32. U.S. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2023
Figure 37. Germany VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2023
Figure 44. China VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (Kilotons)
Figure 50. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2023
Figure 51. Brazil VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Type (2025-2030)
Figure 65. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Application (2025-2030)
Figure 66. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Application (2025-2030)


More Publications